JP2023126245A5 - - Google Patents

Download PDF

Info

Publication number
JP2023126245A5
JP2023126245A5 JP2023101681A JP2023101681A JP2023126245A5 JP 2023126245 A5 JP2023126245 A5 JP 2023126245A5 JP 2023101681 A JP2023101681 A JP 2023101681A JP 2023101681 A JP2023101681 A JP 2023101681A JP 2023126245 A5 JP2023126245 A5 JP 2023126245A5
Authority
JP
Japan
Prior art keywords
lower alkyl
group
fibrosis
independently selected
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023101681A
Other languages
English (en)
Japanese (ja)
Other versions
JP7778745B2 (ja
JP2023126245A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/043335 external-priority patent/WO2019018855A1/en
Application filed filed Critical
Publication of JP2023126245A publication Critical patent/JP2023126245A/ja
Publication of JP2023126245A5 publication Critical patent/JP2023126245A5/ja
Application granted granted Critical
Publication of JP7778745B2 publication Critical patent/JP7778745B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023101681A 2017-07-21 2023-06-21 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤 Active JP7778745B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762535611P 2017-07-21 2017-07-21
US62/535,611 2017-07-21
PCT/US2018/043335 WO2019018855A1 (en) 2017-07-21 2018-07-23 ALPHA PROPELLER PROTEIN KINASE INHIBITORS ("COILED-COIL") ASSOCIATED WITH RHO
JP2020502709A JP7383598B2 (ja) 2017-07-21 2018-07-23 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020502709A Division JP7383598B2 (ja) 2017-07-21 2018-07-23 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Publications (3)

Publication Number Publication Date
JP2023126245A JP2023126245A (ja) 2023-09-07
JP2023126245A5 true JP2023126245A5 (enExample) 2024-03-12
JP7778745B2 JP7778745B2 (ja) 2025-12-02

Family

ID=65015613

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020502709A Active JP7383598B2 (ja) 2017-07-21 2018-07-23 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP2023101681A Active JP7778745B2 (ja) 2017-07-21 2023-06-21 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020502709A Active JP7383598B2 (ja) 2017-07-21 2018-07-23 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Country Status (7)

Country Link
US (1) US11479533B2 (enExample)
EP (1) EP3654970A4 (enExample)
JP (2) JP7383598B2 (enExample)
CN (1) CN111050766A (enExample)
CA (1) CA3070115A1 (enExample)
EA (1) EA202090306A1 (enExample)
WO (1) WO2019018855A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3752497T1 (sl) * 2018-02-16 2024-10-30 Constellation Pharmaceuticals, Inc. Zaviralci P300/CBP HAT
TWI777325B (zh) * 2019-12-31 2022-09-11 財團法人工業技術研究院 β-胺基酸衍生物、含其之激酶抑制劑與醫藥組成物以及其用途
CN111707832B (zh) * 2020-07-16 2023-08-15 首都医科大学附属北京朝阳医院 Rock激酶活性在辅助诊断肾损害中的应用
CN111707830B (zh) * 2020-07-16 2023-08-15 首都医科大学附属北京朝阳医院 Rock激酶活性在辅助诊断肺损害中的应用
EP4440566A4 (en) * 2021-11-29 2025-10-01 Woolsey Pharmaceuticals Inc METHODS FOR TREATING AGITATION AND OTHER BEHAVIORAL SYMPTOMS ASSOCIATED WITH DEMENTIA
WO2024075838A1 (ja) * 2022-10-07 2024-04-11 国立研究開発法人理化学研究所 肺線維症モデル、及び、肺線維症の予防又は治療剤のスクリーニング方法
WO2025017500A1 (en) * 2023-07-17 2025-01-23 Graviton Bioscience Bv Formulations of rock2 inhibitors for cns disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294624B2 (en) 2001-12-20 2007-11-13 Bristol Myers Squibb Company Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
CA2499128C (en) * 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
US8211919B2 (en) * 2005-09-02 2012-07-03 Astellas Pharma Inc. Amide derivatives as rock inhibitors
CA2709879A1 (en) * 2007-12-19 2009-06-25 The Scripps Research Institute Anilides and analogs as rho kinase inhibitors
CN105102448B (zh) * 2013-02-28 2018-03-06 百时美施贵宝公司 作为rock1和rock2抑制剂的苯基吡唑衍生物
WO2015006100A1 (en) * 2013-07-08 2015-01-15 Bristol-Myers Squibb Company Aryl amide kinase inhibitors
US9617214B2 (en) * 2013-11-08 2017-04-11 The Translational Genomics Research Institute Compounds for cognitive enhancement and methods of use thereof
US10035777B2 (en) * 2014-08-05 2018-07-31 Bristol-Myers Squibb Company Heterocyclic kinase inhibitors
JP2020528415A (ja) * 2017-07-21 2020-09-24 カドモン コーポレイション,リミティド ライアビリティ カンパニー Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP7399848B2 (ja) * 2017-09-01 2023-12-18 カドモン コーポレイション,リミティド ライアビリティ カンパニー Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Similar Documents

Publication Publication Date Title
JP2023126245A5 (enExample)
US20110294856A1 (en) Novel oxadiazole derivatives and their medical use
JP2010501587A5 (enExample)
JP2003523988A (ja) フェニルヘテロアルキルアミン誘導体の新規なる使用
RU2356893C2 (ru) Ингибиторы фосфодиэстеразы 4
JP2017025080A (ja) カゼインキナーゼ1δ(CK1δ)阻害剤及びタウオパチーなどの神経変性疾患の治療におけるその使用
JP2013542937A5 (enExample)
JP2010520893A5 (enExample)
KR960014125A (ko) 헤테로사이클 화합물, 이들의 제조방법 및 용도
JP2014037426A5 (enExample)
JP2011509916A5 (enExample)
WO2000075113A1 (en) Novel heterocyclic carboxamide derivatives
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
RU98123074A (ru) Хинолиновые карбоксамиды в качестве ингибиторов фно и фдэ-iv
JP2005539054A5 (enExample)
JP2004532229A5 (enExample)
JP2010513434A5 (enExample)
JPWO2008096870A1 (ja) アザ架橋環化合物
JP2006508987A5 (enExample)
JP2014523400A (ja) 芳香族アミド類およびそれらの使用
JP2020535165A5 (enExample)
JP2019530674A5 (enExample)
JP2005500370A5 (enExample)
JP2006503816A5 (enExample)
JP4622047B2 (ja) 新規なヘテロ環カルボキサミド誘導体